FDA safety alert: Efficacy concerns for a combination therapy in breast cancer treatment
September 16th 2020Officials from the Food and Drug Administration (FDA) issued a safety alert on Sept. 8 about potential efficacy and safety concerns with Tecentriq in combination with Paclitaxel for breast cancer treatment.
Little evidence supports the routine use of activity restriction for preterm birth and other obstetric conditions, and some data indicate adverse impact on obstetric outcomes.
Aleha Aziz, MD, MPH: The fellow on the frontlines of COVID-19
August 31st 2020Senior Editor Angie DeRosa interviews Aleha Aziz, MD, an ob/gyn at Columbia University’s Irving Medical Center in New York. Dr. Aziz was one of many fellows involved with caring for patients during the peak of the COVID-19 pandemic in New York City earlier this year.